Mario Valenti (M Valenti)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 28

Top Topics

Atopic Dermatitis

Top Venues

Dermatologic therapy

Dermatology and therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

The Journal of dermatological treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Giovanni Fiorillo, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study. Journal of personalized medicine 14 (2) (2024)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo G Carrera, Paolo Dapavo, Valentina Dini, Francesca M Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo V Marzano, Martina Maurelli, Matteo Megna, Diego Orsini, Massimo Travaglini, Antonio Costanzo, Alessandra Narcisi
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis). Dermatology and therapy 14 (6) (2024)
Giovanni Paolino, Riccardo Pampena, Sofia Maria Di Ciaccio, Andrea Carugno, Carmen Cantisani, Matteo Riccardo Di Nicola, Luigi Losco, Giulio Bortone, Santo Raffaele Mercuri, Antonio Costanzo, Marco Ardigò, Mario Valenti
Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features. Medicina (Kaunas, Lithuania) 60 (8) (2024)
Giovanni Fiorillo, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study. Journal of personalized medicine 14 (2) (2024)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo G Carrera, Paolo Dapavo, Valentina Dini, Francesca M Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo V Marzano, Martina Maurelli, Matteo Megna, Diego Orsini, Massimo Travaglini, Antonio Costanzo, Alessandra Narcisi
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis). Dermatology and therapy 14 (6) (2024)
Luigi Gargiulo, Luciano Ibba, Matteo Bianco, Sara Di Giulio, Alfano Alfano, Ruggero Cascio Ingurgio, Paola Facheris, Chiara Perugini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study. The Journal of dermatological treatment 35 (1) (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Francesca Maria Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, Orsini Diego, Francesca Sampogna, Massimo Travaglini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of clinical medicine 13 (2) (2024)
Giovanni Fiorillo, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study. Journal of personalized medicine 14 (2) (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Francesca Maria Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, Orsini Diego, Francesca Sampogna, Massimo Travaglini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of clinical medicine 13 (2) (2024)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo G Carrera, Paolo Dapavo, Valentina Dini, Francesca M Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo V Marzano, Martina Maurelli, Matteo Megna, Diego Orsini, Massimo Travaglini, Antonio Costanzo, Alessandra Narcisi
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis). Dermatology and therapy 14 (6) (2024)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo G Carrera, Paolo Dapavo, Valentina Dini, Francesca M Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo V Marzano, Martina Maurelli, Matteo Megna, Diego Orsini, Massimo Travaglini, Antonio Costanzo, Alessandra Narcisi
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis). Dermatology and therapy (2024)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo G Carrera, Paolo Dapavo, Valentina Dini, Francesca M Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo V Marzano, Martina Maurelli, Matteo Megna, Diego Orsini, Massimo Travaglini, Antonio Costanzo, Alessandra Narcisi
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis). Dermatology and therapy 14 (6) (2024)
Francesco Bellinato, Paolo Gisondi, Annunziata Dattola, A G Richetta, Antonio Costanzo, Mario Valenti, Clara De Simone, Angelo Valerio Marzano, M Zussino, Elena Pezzolo, M Nacca, Giovanni Pellacani, Giampiero Girolomoni
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Riccardo G Borroni, Francesco Piscazzi, Mario Valenti, Valeria Rimoldi, Monica Barile, Paolo Pietro Bianchi, Rebecca Favaro, Alessandra Formai, Angelo Selicorni, Sofia Manara, Valeriano Vinci, Andrea Gerardo Lania, Antonio Costanzo
Multiple facial angiofibromas: A manifestation of Frank-ter Haar syndrome? American journal of medical genetics. Part A (2023)
Rebecca Favaro, Alessandra Formai, Giulia Pavia, Luigi Gargiulo, Jessica Avagliano, Mario Valenti, Paola Facheris, Beatrice Salsano, Roberta Valeria Latorre, Francesco Bellinato, Paolo Gisondi, Alessandra Narcisi, Antonio Costanzo
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination. The British journal of dermatology (2023)
Orsini Diego, P Frascione, C Assorgi, A Pacifico, I Sperduti, Luigi Gargiulo, Luciano Ibba, Mario Valenti, Antonio Costanzo, A Narcisi
Risankizumab for the treatment of genital psoriasis: a 1-year, real-world experience. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo
Sub-erythrodermic psoriasis successfully treated with bimekizumab: A case report. Dermatologic therapy (2022)
Mario Valenti, Pierfrancesco De Giacomo, Annamaria Lavecchia, Giancarlo Valenti
A severe case of IgA bullous pemphigoid successfully treated with dupilumab. Dermatologic therapy 35 (11) (2022)
Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, Luciano Ibba, Fabrizio Amoruso, Giuseppe Argenziano, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Giampiero Girolomoni, Claudio Guarneri, Francesco Loconsole, Francesca Sampogna, Massimo Travaglini, Piergiorgio Malagoli, Antonio Costanzo
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis). Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Giulia Pavia, Luigi Gargiulo, F Spinelli, J Avagliano, Mario Valenti, R G Borroni, Antonio Costanzo, A Narcisi
Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (7) (2022)
Alessandra Narcisi, Mario Valenti, Andrea Cortese, Francesco Toso, Giulia Pavia, Luigi Gargiulo, Riccardo Borroni, Antonio Costanzo
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study. Dermatologic therapy (2021)
Mario Valenti, G Pavia, L Gargiulo, P Facheris, F Sanna, R G Borroni, A Costanzo, A Narcisi
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population. The Journal of dermatological treatment (2021)
Alessandra Narcisi, Mario Valenti, Clara De Simone, Maria Esposito, Antonio Richetta, Miriam Teoli, Giuseppe Argento, Antonio Costanzo
Effects of TNF-α inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patients. The Journal of dermatological treatment (2021)
Giulia Pavia, Luigi Gargiulo, Andrea Cortese, Mario Valenti, Federica Sanna, Riccardo G Borroni, Antonio Costanzo, Alessandra Narcisi
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: a real-life single-center retrospective study. Dermatologic therapy (2021)
Paola Facheris, Mariangela Allocca, Mario Valenti, Giulia Pavia, Luigi Gargiulo, Sofia A A M Manara, Alessandra Narcisi, Antonio Costanzo, Riccardo G Borroni
Palmar nodules in a young woman with ulcerative colitis and enteropathic arthritis. International journal of dermatology 60 (6) (2020)
Mario Valenti, L Gargiulo, G Pavia, P Facheris, R Borroni, A Narcisi, A Costanzo
Reorganization of a Northern Italy dermatology department during the COVID-19 pandemic: is it temporary or the beginning of a new era in dermatology? The Journal of dermatological treatment (2020)
Luigi Gargiulo, Giulia Pavia, Paola Facheris, Mario Valenti, Francesco Sacrini, Alessandra Narcisi, Riccardo Borroni, Antonio Costanzo, Luca Livio Mancini
A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever. Dermatologic therapy 33 (4) (2020)
Mario Valenti, Paola Facheris, Giulia Pavia, Luigi Gargiulo, Riccardo Giovanni Borroni, Antonio Costanzo, Alessandra Narcisi
Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab. Dermatologic therapy 33 (4) (2020)